[HTML][HTML] Sensitive periods of substance abuse: Early risk for the transition to dependence

CJ Jordan, SL Andersen - Developmental cognitive neuroscience, 2017 - Elsevier
Early adolescent substance use dramatically increases the risk of lifelong substance use
disorder (SUD). An adolescent sensitive period evolved to allow the development of risk …

Experience during adolescence shapes brain development: From synapses and networks to normal and pathological behavior

D Dow-Edwards, FP MacMaster, BS Peterson… - Neurotoxicology and …, 2019 - Elsevier
Adolescence is a period of dramatic neural reorganization creating a period of vulnerability
and the possibility for the development of psychopathology. The maturation of various neural …

Long-term voluntary wheel running is rewarding and produces plasticity in the mesolimbic reward pathway

BN Greenwood, TE Foley, TV Le, PV Strong… - Behavioural brain …, 2011 - Elsevier
The mesolimbic reward pathway is implicated in stress-related psychiatric disorders and is a
potential target of plasticity underlying the stress resistance produced by repeated voluntary …

[HTML][HTML] Stress, sensitive periods, and substance abuse

SL Andersen - Neurobiology of stress, 2019 - Elsevier
Research on the inter-relationship between drug abuse and social stress has primarily
focused on the role of stress exposure during adulthood and more recently, adolescence …

Neurobehavioral changes arising from early life dopamine signaling perturbations

LB Areal, RD Blakely - Neurochemistry international, 2020 - Elsevier
Dopamine (DA) signaling is critical to the modulation of multiple brain functions including
locomotion, reinforcement, attention and cognition. The literature provides strong evidence …

Enduring effects of adolescent ketamine exposure on cocaine-and sucrose-induced reward in male and female C57BL/6 mice

I Garcia-Carachure, FJ Flores-Ramirez… - …, 2020 - nature.com
Ketamine has shown promising antidepressant efficacy for adolescent treatment-resistant
depression. However, the potential enduring consequences of ketamine exposure have not …

Addiction-related gene regulation: Risks of exposure to cognitive enhancers vs. other psychostimulants

H Steiner, V Van Waes - Progress in neurobiology, 2013 - Elsevier
The psychostimulants methylphenidate (Ritalin, Concerta), amphetamine (Adderall), and
modafinil (Provigil) are widely used in the treatment of medical conditions such as attention …

Behavioral, neurochemical and developmental effects of chronic oral methylphenidate: a review

D Senior, R Ahmed, E Arnavut, A Carvalho… - Journal of Personalized …, 2023 - mdpi.com
The majority of animal studies on methylphenidate (MP) use intraperitoneal (IP) injections,
subcutaneous (SC) injections, or the oral gavage route of administration. While all these …

Methylphenidate amplifies the potency and reinforcing effects of amphetamines by increasing dopamine transporter expression

ES Calipari, MJ Ferris, A Salahpour, MG Caron… - Nature …, 2013 - nature.com
Methylphenidate (MPH) is commonly diverted for recreational use, but the neurobiological
consequences of exposure to MPH at high, abused doses are not well defined. Here we …

[HTML][HTML] Fluoxetine potentiates methylphenidate-induced behavioral responses: enhanced locomotion or stereotypies and facilitated acquisition of cocaine self …

L Lamoureux, JA Beverley, M Marinelli, H Steiner - Addiction neuroscience, 2023 - Elsevier
The medical psychostimulant methylphenidate (MP) is used to treat attention-deficit
hyperactivity disorder and recreationally as a “cognitive enhancer”. MP is a dopamine …